Loading data
FNGRNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 24.13 m USD | 35.61 m USD | 35.79 m USD | 34.05 m USD | 22.93 m USD |
| Cost of revenue | 23.44 m USD | 32.84 m USD | 31.93 m USD | 31.74 m USD | 20.11 m USD |
| Gross profit | 693.85 k USD | 2.76 m USD | 3.86 m USD | 2.32 m USD | 2.81 m USD |
| Research and development expense | 411.93 k USD | 632.77 k USD | 699.56 k USD | 797.55 k USD | 923.39 k USD |
| Operating profit | -6.94 m USD | -5.95 m USD | -3.82 m USD | -6.67 m USD | -4.87 m USD |
| Interest expense | — | — | 121.45 k USD | 566.08 k USD | 170.14 k USD |
| Profit before tax | -7.04 m USD | -5.99 m USD | -3.81 m USD | -7.54 m USD | -4.94 m USD |
| Income tax expense | — | -879.12 k USD | — | — | — |
| Net income (reported basis) | -7.04 m USD | -5.11 m USD | -3.81 m USD | -7.54 m USD | -4.94 m USD |
| Net income attributable to common shareholders | -7 m USD | -5.11 m USD | 3.81 m USD | -7.54 m USD | — |
| Basic earnings per share | -0.12 USD/share | -0.09 USD/share | -0.07 USD/share | -0.17 USD/share | -0.12 USD/share |
| Diluted earnings per share | -0.12 USD/share | -0.09 USD/share | -0.07 USD/share | -0.17 USD/share | -0.12 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.